Published in Int J Obes (Lond) on May 26, 2017
Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22
Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) (2005) 9.85
Polycystic ovary syndrome. N Engl J Med (1995) 5.30
A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol (2008) 5.07
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation (2006) 4.25
Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet (2012) 4.08
Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest (2011) 3.23
Metabolic phenotyping in health and disease. Cell (2008) 2.80
Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 2.52
Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab (2005) 2.50
Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2011) 2.49
High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst (2009) 2.49
Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet (2010) 2.34
Metabonomic, transcriptomic, and genomic variation of a population cohort. Mol Syst Biol (2010) 2.17
High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med (2009) 2.02
Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol (2008) 1.92
Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab (2001) 1.89
Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes (2012) 1.80
Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) (2006) 1.76
Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr (2005) 1.66
Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation (2012) 1.64
Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med (2014) 1.60
Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes (2002) 1.43
Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab (1985) 1.43
Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf) (2007) 1.31
Metabolic cardiovascular disease risk factors in women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. J Clin Endocrinol Metab (2004) 1.30
Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab (1994) 1.28
Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab (2005) 1.21
Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study. J Clin Endocrinol Metab (2003) 1.21
Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study. Ann Intern Med (2011) 1.20
Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics. Clin Chem Lab Med (2008) 1.13
Effects of methyltestosterone on insulin secretion and sensitivity in women. J Clin Endocrinol Metab (1998) 1.11
Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol (Oxf) (2001) 1.10
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) (1992) 1.07
Long-term testosterone administration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metab (1997) 1.02
Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS. J Clin Endocrinol Metab (2010) 1.01
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril (2011) 1.01
Metabolic Evidence of Diminished Lipid Oxidation in Women With Polycystic Ovary Syndrome. Curr Metabolomics (2014) 0.99
Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med (2012) 0.98
Testosterone increases the muscle protein synthesis rate but does not affect very-low-density lipoprotein metabolism in obese premenopausal women. Am J Physiol Endocrinol Metab (2012) 0.92
The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clin Endocrinol (Oxf) (2000) 0.91
Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod (2004) 0.90
Hyperandrogenism Accompanies Increased Intra-Abdominal Fat Storage in Normal Weight Polycystic Ovary Syndrome Women. J Clin Endocrinol Metab (2016) 0.90
Cyclical variation of plasma lipids, apolipoproteins, and lipoprotein(a) during menstrual cycle of normal women. Am J Physiol (1995) 0.88
Altered composition of high density lipoproteins in women with the polycystic ovary syndrome. J Clin Endocrinol Metab (1997) 0.88
Polycystic ovary syndrome (PCOS) and other androgen excess-related conditions: can changes in dietary intake make a difference? Nutr Clin Pract (2008) 0.82
Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry. J Proteome Res (2014) 0.81
Quantitative high-throughput metabolomics: a new era in epidemiology and genetics. Genome Med (2012) 0.81
Lipidomic analysis of plasma samples from women with polycystic ovary syndrome. Metabolomics (2014) 0.79
Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach. Anal Bioanal Chem (2015) 0.79
Metabolomics in polycystic ovary syndrome. Clin Chim Acta (2013) 0.78
Editorial-data analysis in metabolomics. Metabolomics (2012) 0.76
Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study. Hum Reprod (2014) 0.89
Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study. Hum Reprod (2014) 0.77